COP
45
-2
KIM
48
-6
HSY
66
2
TEL
86
-2
HAL
47
3
PSA
48
2
HPE
48
-2
PHM
70
-4
V
70
-2
CI
46
-6
ALL
48
3
SHW
62
-2
AON
28
3
TXT
70
-3
DOV
79
-4
ETN
80
-7
PSX
45
-2
TROW
59
-2
HBAN
54
-3
GOOGL
72
13
COP
45
-2
KIM
48
-6
HSY
66
2
TEL
86
-2
HAL
47
3
PSA
48
2
HPE
48
-2
PHM
70
-4
V
70
-2
CI
46
-6
ALL
48
3
SHW
62
-2
AON
28
3
TXT
70
-3
DOV
79
-4
ETN
80
-7
PSX
45
-2
TROW
59
-2
HBAN
54
-3
GOOGL
72
13
Financhill
Back

Amicus Therapeutics Stock Predictions

Sell
31

FOLD
Amicus Therapeutics

Last Price:
9.50
Seasonality Move:
24.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Amicus Therapeutics Stock Forecast

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 21.9% based on the past 16 years of stock performance.
  • Amicus Therapeutics has risen higher in 5 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 31.25%
  • Is Amicus Therapeutics Stock Undervalued?
    The current Amicus Therapeutics [FOLD] share price is $9.50. The Score for FOLD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 21.9% based on the past 16 years of stock performance.

Amicus Therapeutics Stock Rating

Sell
31
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics overpriced?

  • Amicus Therapeutics has risen higher in 5 of those 16 years over the subsequent 52-week period, corresponding to a historical accuracy of 31.25%

Amicus Therapeutics Stock Price History

Is FOLD stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com

52-Week Data

52-Week High:
14.57
52-Week Low:
9.02

Prediction Charts

Market Cap:
2.81B
Price in USD:
9.50
Volume:
2.38M
Beta:
1.03

Technical Analysis

SMA50:
10.93
SMA100:
12.09
SMA200:
11.96
52-Wk Change:
-11.38%

Stock Predictions

  • Is Amicus Therapeutics stock public?
    Yes, Amicus Therapeutics is a publicly traded company.
  • What is the Amicus Therapeutics stock quote today?
    The Amicus Therapeutics stock price is 9.50 USD today.
  • How to buy Amicus Therapeutics stock online?
    You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 10.38 10.25 10.52 10.24
Apr-30 10.17 9.99 10.23 9.96
May-1 10.09 10.42 10.60 9.98
May-2 10.51 10.42 10.61 10.37
May-3 10.74 10.40 10.79 10.36
May-6 10.39 10.34 10.46 10.29
May-7 10.40 10.41 10.57 10.26
May-8 10.26 10.14 10.38 10.11
May-9 9.97 9.47 10.00 9.24
May-10 9.50 9.23 9.56 9.13
May-13 9.33 9.03 9.45 9.02
May-14 9.49 9.33 9.63 9.13
May-15 9.54 9.66 9.80 9.47
May-16 9.61 9.50 9.63 9.28

Amicus Therapeutics Earnings

Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics Forecast Revenue Growth

Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.03 per share, an increase this year of $0.50 per share, and an increase next year of $0.40 per share.

* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.